Thyroid Hormone-Mediated Growth and Differentiation of Growth Plate Chondrocytes Involves IGF-1 Modulation of β-Catenin Signaling

被引:109
作者
Wang, Lai
Shao, Yvonne Y.
Ballock, R. Tracy [1 ]
机构
[1] Cleveland Clin Fdn, Dept Orthopaed Surg, Orthopaed Res Ctr, Lerner Res Inst, Cleveland, OH 44195 USA
基金
美国国家卫生研究院;
关键词
THYROID HORMONE; INSULIN-LIKE GROWTH FACTOR 1; beta-CATENIN; GROWTH PLATE CHONDROCYTES; FACTOR-I; GENE-EXPRESSION; CELL-PROLIFERATION; POSTNATAL-GROWTH; BONE-GROWTH; MICE; CARTILAGE; PATHWAYS; RECEPTOR; HYPERTROPHY;
D O I
10.1002/jbmr.5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Thyroid hormone regulates terminal differentiation of growth plate chondrocytes in part through modulation of the Wnt/beta-catenin signaling pathway. Insulin-like growth factor 1 (IGF-1) has been described as a stabilizer of beta-catenin, and thyroid hormone is a known stimulator of IGF-1 receptor expression. The purpose of this study was to test the hypothesis that IGF-1 signaling is involved in the interaction between the thyroid hormone and the Wnt/beta-catenin signaling pathways in regulating growth plate chondrocyte proliferation and differentiation. The results show that IGF-1 and the IGF- receptor (IGF1R) stimulate Wnt-4 expression and beta-catenin activation in growth plate chondrocytes. The positive effects of IGF-1/IGF1R on chondrocyte proliferation and terminal differentiation are partially inhibited by the Wnt antagonists sFRP3 and Dkk1. T-3 activates IGF-1/IGF1R signaling and IGF-1-dependent PI3K/Akt/GSK-3 beta signaling in growth plate chondrocytes undergoing proliferation and differentiation to prehypertrophy. T-3-mediated Wnt-4 expression, beta-catenin activation, cell proliferation, and terminal differentiation of growth plate chondrocytes are partially prevented by the IGF1R inhibitor picropodophyllin as well as by the PI3K/Akt signaling inhibitors LY294002 and Akti1/2. These data indicate that the interactions between thyroid hormone and beta-catenin signaling in regulating growth plate chondrocyte proliferation and terminal differentiation are modulated by IGF-1/IGF1R signaling through both the Wnt and PI3K/Akt signaling pathways. While chondrocyte proliferation may be triggered by the IGF-1/IGF1R-mediated PI3K/Akt/GSK3 beta pathway, cell hypertrophy is likely due to activation of Wnt/beta-catenin signaling, which is at least in part initiated by IGF-1 signaling or the IGF-1-activated PI3K/Akt signaling pathway. (C) 2010 American Society for Bone and Mineral Research.
引用
收藏
页码:1138 / 1146
页数:9
相关论文
共 50 条
  • [11] Growth hormone and IGF-1 as doping agents in competitive sport
    Jozkow, Pawel
    Medras, Marek
    ENDOKRYNOLOGIA POLSKA, 2009, 60 (05) : 389 - 394
  • [12] Growth Hormone, Not IGF-1 Is the Key Longevity Regulator in Mammals
    Brown-Borg, Holly M.
    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2022, 77 (09): : 1719 - 1723
  • [13] How to interpret IGF-1 and growth hormone stimulation tests
    Tseretopoulou, Xanthippi
    Mushtaq, Talat
    ARCHIVES OF DISEASE IN CHILDHOOD-EDUCATION AND PRACTICE EDITION, 2020, 105 (05): : 311 - 314
  • [14] Growth hormone STAT5-mediated signaling and its modulation in mice liver during the growth period
    Martinez, Carolina S.
    Piazza, Veronica G.
    Ratner, Laura D.
    Matos, Marina N.
    Gonzalez, Lorena
    Rulli, Susana B.
    Miquet, Johanna G.
    Sotelo, Ana I.
    GROWTH HORMONE & IGF RESEARCH, 2013, 23 (1-2) : 19 - 28
  • [15] Differential effects of STAT proteins on growth hormone-mediated IGF-I gene expression
    Varco-Merth, Ben
    Rotwein, Peter
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2014, 307 (09): : E847 - E855
  • [16] IMPACT OF THE GROWTH HORMONE AND IGF-1 ON GRAFT FUNCTION AND IMMUNE RESPO NSE IN PEDIATRIC LIVER RECIPIENTS
    Kurabekova, R. M.
    Tsirulnikova, O. M.
    Oleshkevich, S. Yu
    Pashkova, I. E.
    Olefirenko, G. A.
    VESTNIK TRANSPLANTOLOGII I ISKUSSTVENNYH ORGANOV, 2022, 24 (02): : 65 - 70
  • [17] Insulin-like growth factor 1 (IGF-1) regulates prolactin, growth hormone, and IGF-1 receptor expression in the pituitary gland of the gilthead sea bream Sparus aurata
    Mohammed-Geba, Khaled
    Martos-Sitcha, J. A.
    Galal-Khallaf, A.
    Mancera, J. M.
    Martinez-Rodriguez, G.
    FISH PHYSIOLOGY AND BIOCHEMISTRY, 2016, 42 (01) : 365 - 377
  • [18] Disease tolerance mediated by microbiome E-coli involves inflammasome and IGF-1 signaling
    Schieber, Alexandria M. Palaferri
    Lee, Yujung Michelle
    Chang, Max W.
    Leblanc, Mathias
    Collins, Brett
    Downes, Michael
    Evans, Ronald M.
    Ayres, Janelle S.
    SCIENCE, 2015, 350 (6260) : 558 - 563
  • [19] An Evaluation of Growth Hormone and IGF-1 Responses in Neonates with Hyperinsulinaemic Hypoglycaemia
    Senniappan, Senthil
    Hussain, Khalid
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2013, 2013
  • [20] Effects of recombinant human growth hormone in the treatment of dwarfism and relationship between IGF-1, IGFBP-3 and thyroid hormone
    Ren, Shanxiang
    Nie, Yuxiang
    Wang, Aihong
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 12 (06) : 3579 - 3582